AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 51 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.06 and the average weighting 2.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $65,000 | -36.9% | 103,100 | -13.5% | 0.00% | – |
Q3 2019 | $103,000 | -2.8% | 119,200 | -24.7% | 0.00% | – |
Q2 2019 | $106,000 | -88.3% | 158,245 | -71.6% | 0.00% | -100.0% |
Q4 2018 | $908,000 | +17.5% | 556,845 | +138.4% | 0.00% | +50.0% |
Q3 2018 | $773,000 | +61.7% | 233,566 | +41.5% | 0.00% | +100.0% |
Q2 2018 | $478,000 | 0.0% | 165,015 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $478,000 | -9.0% | 165,015 | +14.7% | 0.00% | -50.0% |
Q3 2017 | $525,000 | +136.5% | 143,913 | +38.8% | 0.00% | +100.0% |
Q2 2017 | $222,000 | +335.3% | 103,718 | +80.4% | 0.00% | – |
Q3 2016 | $51,000 | – | 57,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
Caption Management, LLC | 855,200 | $701,000 | 0.04% |
Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |